Jorgensen, Leif : Experimental Platelet and Coagulation Thrombi . Acta Path. et Microbiol., Scandinav.,62: 189, 1964.
2.
Danese, C.A. , Voleti, D.C. and Weiss, J.H.: Protection by Aspirin against Experimentally Induced Arterial Thrombosis in Dogs. Thromb. Diath. Haemorrh.,25: 288, 1971.
3.
Danese, C.A. and Haimov, M.: Inhibition of Experimental Arterial Thrombosis in Dogs with Platelet Deaggregating Agents. Surgery, 70: 927, 1971.
4.
Didisheim, P. : Inhibition of Dipyridamole of Arterial Thrombosis in Rats. Thromb. Diath. Haemorrh.,20: 257, 1968.
5.
Sullivan, J.M. , Harken, D.E. and Gorlin, R.: Pharmacologic Control of Thromboembolic Complications of Cardiac Valve Replacements. New Eng. J. Med., 279: 576, 1968.
6.
Lendrum, A.C. , Fraser, D.S., Slidders , W. and Henderson, R.: Studies on the Character and Staining of Fibrin. J. Clin. Path., 15: 401, 1962.
7.
Bell, W.R., Pitney, W.R., Oakley, C.M. and Goodwin, J.F.: Therapeutic Defibrination in the Treatment of Thrombotic Disease. Lancet, 1: 490, 1968.
8.
Esnouf, M.P. and Tumah, G.W.: The Isolation and Properties of the Thrombin-Like Activity from Ankistrodon Rhodostoma Venom. Brit. J. Haemat. , 13: 581, 1967.
9.
Sharp, A.A., Warren, B.A., Paxton, A.M. and Allington, M.J.: Anticoagulant Therapy with a Purified Fraction of Malayian Pit Viper Venom . Lancet, 1: 493, 1968.
10.
Reid, H.A. and Chan, K.E.: The Paradox in Therapeutic Defibrination. Lancet, 1: 485, 1968.
11.
Kwaan, H.C. and Barlow, G.H.: The Mechanism of Action of a Coagulant Fraction of Malayian Pit Viper Venom, Arvin and of Reptilase. Suppl. XLV: 63, 1971, Thromb. Diath. Haemorrh., 35: 63, 1971.
12.
Laurent, T.C. and Blomback, B.: On the Significance of the Release of Two Different Peptides from Fibrinogen during Clotting. Acta Chem. Scand., 12: 12, 1958.
13.
Blomback, B. , Blomback, M., Edman , P. and Hassel, B.: Human Fibrinopeptides. Isolation, Characterization and Structure. Biochem. Biophys. Acta, 115: 371, 1966 .
14.
Holleman, W.H. and Coen, L.J.: Characteristics of Peptides Released from Human Fibrinogen by Arvin. Biochem. Biophys. Acta, 200: 587, 1970.
15.
Rahimtoola, S.H., Raphael, M.J., Olsen , E.G.J. and Pitney, W.R.: Therapeutic Defibrination in the Prevention and Resolution of Experimental Venous Thrombosis . Circulation , 40, suppl., 3: 166, 1969.
16.
Singh, M.P. , Bentall, H.H., Bell , W.R., Olsen, E.G.J. and Allwoik , S.P.: The Use of Ancrod to Prevent Thrombosis on Prosthetic Heart Valves. Thorax, 25: 472, 1970.
17.
Bell, W.R., Pitney, W.R., Oakley, C.M. and Goodwin, J.F.: Therapeutic Defibrination in the Treatment of Thrombotic Disease. Lancet, 1: 490, 1968.
Deykin, D.: The Use of Heparin. New Eng. J. Med., 280: 937, 1969.
20.
Weiss, H.J. and Rogers, J.: Fibrinogen and Platelets in the Primary Arrest of Bleeding. New Eng. J. Med., 285: 369, 1971 .
21.
Slade, C.L. , Taylor, L.M., Wechsler , A. and McKee, P.A.: A Comparison of Post-surgical Hemorrhage in Dogs Treated with Arvin or Heparin. Circulation, suppl., 46: 222, 1972.
